Bristol Myers Squibb Co
BMY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000014272
In the last 90 days, Bristol Myers Squibb Co insiders filed 0 open-market purchases and 2 sales; 2,529 institutions reported holding it in 13F filings for Q2 2026, worth $96.7B in total; no superinvestor holds it.
Other share classesCELG.RI
Q3 2021 vs. Q2 2021
How the institutions holding Bristol Myers Squibb Co changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 2,379 | 35 | 2,299 | −45 |
| Shares | 1.63B | 2.00M | 1.63B | +1.16M (+0.1%) |
| Value | $109.0B | $133.4M | $96.6B | −$12.2B (−11.3%) |
35 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (107)
Institutions that held Bristol Myers Squibb Co at the end of Q3 2021 but not at the end of Q2 2021.
Showing the largest 100 of 107 by value.
Sold out (152)
Institutions that held Bristol Myers Squibb Co at the end of Q2 2021 and filed for Q3 2021 without it.
Showing the largest 100 of 152 by value.
Not filed for Q3 2021 yet (35)
Institutions that held Bristol Myers Squibb Co at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.